Vered Bisker-Leib
Director/Board Member at AYALA PHARMACEUTICALS, INC.
Net worth: 1 M $ as of 2024-05-30
Profile
Vered Bisker-Leib is the founder of Imara, Inc. She currently holds the position of Independent Director at Ayala Pharmaceuticals, Inc. since 2020 and Manager at Compass Therapeutics LLC since 2017.
Previously, she served as Director at Advaxis, Inc. and Chief Business Officer at Cydan II, Inc. from 2014 to 2016.
She was also a Member-Strategic Transactions Group at Bristol Myers Squibb Co. from 2008 to 2013.
Additionally, she has held the role of President & Chief Operating Officer at Compass Therapeutics, Inc. from 2017 to 2024.
Dr. Bisker-Leib's education includes an MBA and a doctorate from the University of Massachusetts, as well as an undergraduate degree from Technion-Israel Institute of Technology.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
| 2024-03-30 | 771,301 ( 0.56% ) | 1 M $ | 2024-05-30 |
Vered Bisker-Leib active positions
| Companies | Position | Start |
|---|---|---|
| AYALA PHARMACEUTICALS, INC. | Director/Board Member | 2020-07-31 |
Compass Therapeutics LLC
 Compass Therapeutics LLC BiotechnologyHealth Technology Compass Therapeutics LLC operates as a healthcare industry focusing on biotechnology. It offers drug discovery, development, biologics, oncology and immuno-oncology. The company was founded by Errik B. Anderson and Thomas J. Schuetz in 2014 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
Former positions of Vered Bisker-Leib
| Companies | Position | End |
|---|---|---|
| COMPASS THERAPEUTICS, INC. | Chief Executive Officer | 2024-05-27 |
| ADVAXIS, INC. | Director/Board Member | 2023-01-18 |
Cydan II, Inc.
 Cydan II, Inc. Pharmaceuticals: GenericHealth Technology Cydan II, Inc. develops and commercializes drugs for orphan and diseases. The firm evaluates products for treating rare diseases with high unmet medical need to start multiple companies to develop such therapies. The company was founded by Cristina Csimma, James G. McArthur, Deborah S. Geraghty and Christoph M. Adams in 2013 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 2016-10-31 |
| BRISTOL-MYERS SQUIBB COMPANY | Corporate Officer/Principal | 2012-12-31 |
| AYALA PHARMACEUTICALS, INC. | Director/Board Member | - |
Training of Vered Bisker-Leib
| University of Massachusetts | Doctorate Degree |
| Technion-Israel Institute of Technology | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 3 |
|---|---|
| COMPASS THERAPEUTICS, INC. | Health Technology |
| BRISTOL-MYERS SQUIBB COMPANY | Health Technology |
| AYALA PHARMACEUTICALS, INC. | Commercial Services |
| Private companies | 6 |
|---|---|
Cydan II, Inc.
Cydan II, Inc. Pharmaceuticals: GenericHealth Technology Cydan II, Inc. develops and commercializes drugs for orphan and diseases. The firm evaluates products for treating rare diseases with high unmet medical need to start multiple companies to develop such therapies. The company was founded by Cristina Csimma, James G. McArthur, Deborah S. Geraghty and Christoph M. Adams in 2013 and is headquartered in Cambridge, MA. | Health Technology |
Compass Therapeutics LLC
Compass Therapeutics LLC BiotechnologyHealth Technology Compass Therapeutics LLC operates as a healthcare industry focusing on biotechnology. It offers drug discovery, development, biologics, oncology and immuno-oncology. The company was founded by Errik B. Anderson and Thomas J. Schuetz in 2014 and is headquartered in Cambridge, MA. | Health Technology |
Olivia Ventures, Inc.
 Olivia Ventures, Inc. Financial ConglomeratesFinance Olivia Ventures, Inc. is a blank check company. It acts as a vehicle to investigate and to pursue a business combination. The company was founded on March 20, 2018 and is headquartered in Boca Raton, FL. | Finance |
Old Ayala, Inc.
 Old Ayala, Inc. Pharmaceuticals: MajorHealth Technology Old Ayala, Inc. operates as a clinical-stage oncology company. It focuses on developing and commercializing small molecule therapeutics for patients suffering from rare and aggressive cancers. It also involved in in precision oncology, targeted therapy, drug development, companion diagnostics, and biomarkers. The company was founded in November 2017 and is headquartered in Rehovot, Israel. | Health Technology |
Imara, Inc.
 Imara, Inc. Pharmaceuticals: MajorHealth Technology Imara, Inc. is a biopharmaceutical company, which engages in the development and commercialization of novel therapeutics to treat patients suffering from hemoglobinopathies. The company was founded by James Gregg McArthur in 2016 and is headquartered in Brookline, MA. | Health Technology |
Advaxis, Inc.
 Advaxis, Inc. Pharmaceuticals: MajorHealth Technology Advaxis, Inc. is a biotechnology company, which engages in the discovery, development and commercialization of cancer immunotherapies. It manages platform technology that utilizes live attenuated Listeria monocytogenes bioengineered to secrete antigen or adjuvant fusion proteins. The firm has four franchises in various stages of clinical and pre-clinical development, namely: HPV-associated cancers, prostate cancer, neoantigen therapy and hotspot mutation therapy. The company was founded on June 5, 1987 and is headquartered in Princeton, NJ. | Health Technology |
- Stock Market
- Insiders
- Vered Bisker-Leib
